Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Nat Commun ; 15(1): 196, 2024 Jan 03.
Article in English | MEDLINE | ID: mdl-38172183

ABSTRACT

Wave phenomena can be artificially engineered by scattering from metasurfaces, which aids in the design of radio-frequency and optical devices for wireless communication, sensing, imaging, wireless power transfer and bio/medical applications. Scattering responses vary with changing frequency; conversely, they remain unchanged at a constant frequency, which has been a long-standing limitation in the design of devices leveraging wave scattering phenomena. Here, we present metasurfaces that can scatter incident waves according to two variables-the frequency and pulse width-in multiple bands. Significantly, these scattering profiles are characterized by how the frequencies are used in different time windows due to transient circuits. In particular, by using more than one frequency with coupled transient circuits, we demonstrate variable scattering profiles in response to unique frequency sequences, which can break a conventional linear frequency concept and markedly increase the available frequency channels in accordance with a factorial number of frequencies used. Our proposed concept, which is analogous to frequency hopping in wireless communication, advances wave engineering in electromagnetics and related fields.

2.
Environ Res ; 231(Pt 1): 115992, 2023 Aug 15.
Article in English | MEDLINE | ID: mdl-37121352

ABSTRACT

Phosphate recovery from wastewater using readily available biowaste-based adsorbents is beneficial for both eutrophication control and waste management. Bamboo char has a high-density porous structure and eggshell contains CaCO3 with high affinity for phosphate. The combination of calcined bamboo and eggshell is a potential adsorbent for P recovery that has not been tested previously. Because bamboo char and eggshell both are popular for soil amendment, a P-loaded bamboo and eggshell composite is a promising fertilizer for long-term soil improvement. In this work, the feasibility of calcined bamboo and eggshell (BE) for P recovery and its use as fertilizer were investigated. The adsorption capacity and mechanism were examined using adsorption kinetic, isotherm, and thermodynamic analysis. The kinetic study showed that the experimental data sets were fitted best by a pseudo second-order model, indicating chemisorption. The Langmuir isotherm model estimated maximum adsorption capacities of 95.14 and 98.40 mg/g for BE 1:1 and 2:1 adsorbent. Monolayer adsorption occurred on a homogenous surface. The adsorption reaction was non-spontaneous at 298 K and exothermic for the BE 1:1 and 2:1 adsorbent, and the calculated Langmuir separation factor indicated favorable conditions for P adsorption. The desorption study showed lower P desorption capacity in water than in neutral ammonium citrate. P-loaded eggshell-modified bamboo char was an effective slow-release fertilizer for Japanese mustard spinach cultivation, which is a sustainable and environment friendly use of P-loaded materials.


Subject(s)
Phosphates , Water Pollutants, Chemical , Animals , Phosphates/analysis , Fertilizers/analysis , Egg Shell/chemistry , Water Pollutants, Chemical/analysis , Wastewater , Adsorption , Kinetics , Hydrogen-Ion Concentration
3.
Nat Commun ; 14(1): 633, 2023 Feb 06.
Article in English | MEDLINE | ID: mdl-36746941

ABSTRACT

Wireless communications and sensing have notably advanced thanks to the recent developments in both software and hardware. Although various modulation schemes have been proposed to efficiently use the limited frequency resources by exploiting several degrees of freedom, antenna performance is essentially governed by frequency only. Here, we present an antenna design concept based on metasurfaces to manipulate antenna performances in response to the time width of electromagnetic pulses. We numerically and experimentally show that by using a proper set of spatially arranged metasurfaces loaded with lumped circuits, ordinary omnidirectional antennas can be reconfigured by the incident pulse width to exhibit directional characteristics varying over hundreds of milliseconds or billions of cycles, far beyond conventional performance. We demonstrate that the proposed concept can be applied for sensing, selective reception under simultaneous incidence and mutual communications as the first step to expand existing frequency resources based on pulse width.

4.
ACS Omega ; 7(8): 6900-6910, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-35252682

ABSTRACT

A series of ethylene copolymers with long-chain α-olefins [LCAOs, 1-dodecene (DD), 1-tetradecene (TD), 1-hexadecene (HD)] and various LCAO contents were prepared, and their thermal properties, including effects of LCAO content and side chain length, were explored. The Cp*TiCl2(O-2,6- i Pr2-4-SiEt3-C6H2)-MAO catalyst system afforded rather high-molecular-weight copolymers with unimodal molecular weight distributions and uniform compositions (confirmed by DSC thermograms). In addition to the melting temperatures (T m values) corresponding to the so-called main chain crystallization (samples with low LCAO contents, the T m value decreased upon increasing the LCAO content) and the side chain crystallization [polymer samples with high LCAO contents, by intermolecular interaction of side chains as observed in poly(DD), poly(TD), and poly(HD)], the other T m value was observed, especially in poly(ethylene-co-HD)s (assumed to be due to co-crystallization of the branch and the main chain through an interaction of the main chain and the long side chains). The presence of another crystalline phase in poly(ethylene-co-HD)s was also suggested by a wide-angle X-ray diffraction (WAXD) analysis. These T m values in poly(ethylene-co-TD)s and poly(ethylene-co-DD)s with rather high TD or DD contents were affected by the heating conditions in the measurement of DSC thermograms (5 or 10 °C/min), suggesting that the driving force for formation of the crystal packing (observed as T m) is weak and affected by the alkyl side chain lengths.

5.
Chem Asian J ; 17(4): e202101341, 2022 Feb 14.
Article in English | MEDLINE | ID: mdl-34939334

ABSTRACT

During the self-assembly of π-conjugated molecules, linkers and substituents can potentially add supportive noncovalent intermolecular interactions to π-stacking interactions. Here, we report the self-assembly behavior of thienopyrrole-fused thiadiazole (TPT) fluorescent dyes that possess ester or ether linkers and dodecyloxy side chains in solution and the condensed phase. A comparison of the self-association behavior of the ester- and ether-bridged compounds in solution using detailed UV-vis, fluorescence, and NMR spectroscopic studies revealed that the subtle replacement of the ether linkers by ester linkers leads to a distinct increase in the association constant (ca. 3-4 fold) and the enthalpic contribution (ca. 3 kcal mol-1 ). Theoretical calculations suggest that the ester linkers, which are in close proximity to one another due to the π-stacking interactions, induce attractive electrostatic forces and augment self-association. The self-assembly of TPT dyes into well-defined 1D clusters with high aspect ratios was observed, and their morphologies and crystallinity were investigated using SEM and X-ray diffraction analyses. TPTs with ester linkers exhibit a columnar liquid crystalline mesophase in the condensed phase.


Subject(s)
Thiadiazoles , Esters , Ether , Ethers , Pyrroles , Static Electricity
6.
Gan To Kagaku Ryoho ; 49(13): 1440-1442, 2022 Dec.
Article in Japanese | MEDLINE | ID: mdl-36733095

ABSTRACT

A 66-year-old man with severe anemia was diagnosed with gastric cancer. CT examination revealed primary gastric tumor, which involved the pancreas body, with regional lymph nodes that were enlarged(T4b[panc], cN2, cM0, cStage ⅣA). He received three courses of preoperative S-1 plus oxaliplatin therapy. Primary tumor and metastatic lymph nodes were reduced remarkably. We performed a curative distal gastrectomy(D2)without pancreas resection. Histopathological examination revealed Grade 3 pathological complete response in both primary tumor and metastatic lymph nodes.


Subject(s)
Stomach Neoplasms , Male , Humans , Aged , Stomach Neoplasms/drug therapy , Stomach Neoplasms/surgery , Stomach Neoplasms/pathology , Oxaliplatin/therapeutic use , Gastrectomy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Oxonic Acid , Tegafur , Drug Combinations , Pancreas/pathology , Neoadjuvant Therapy
7.
Macromol Rapid Commun ; 42(8): e2000558, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33244811

ABSTRACT

Soft tissue in biological system is a hydrogel with elaborate structure exhibiting repeatable dynamic function. In order to approach such sophisticated system, precise construction of a designed network with multi-components is desired. This communication presents a novel hydrogel having highly dense stimuli-responsive free-end chains around crosslinking structure. A key molecule is a core-crosslinked star-shaped polymer with multiple thermoresponsive arms, which can be prepared by reversible addition-fragmentation chain transfer polymerization of divinyl crosslinker with poly(N-isopropylacrylamide) (PNIPAAm) macro-chain transfer agent and have a number of unreacted carbon-carbon double bonds in the core. These unreacted double bonds can be utilized as a crosslinker for poly(acrylamide) (PAAm) gel synthesis by free radical polymerization. The obtained gel contains homogeneously dispersed star PNIPAAms as crosslinking points and exhibits thermoresponsive swelling behavior in water depending on the star contents. In particular, the gel with low content of the star crosslinker shows localized responsive behavior with expansion and shrinkage of the star in one molecule. The mechanical properties of the star-crosslinked gel are significantly high compared to the conventional PAAm gels particularly in compressive strength (≈9 MPa). Moreover, the star-crosslinked gel has thermoresponsive mechanical toughening property.


Subject(s)
Hydrogels , Polymers , Compressive Strength , Polymerization , Water
8.
Gan To Kagaku Ryoho ; 45(3): 566-568, 2018 Mar.
Article in Japanese | MEDLINE | ID: mdl-29650940

ABSTRACT

The patient was a male in his early 60s. Diabetes had aggravated 6 months earlier, and the patient was referred to our hospital for close examination. On contrast CT, enhanced mass shadows filling the lumen of the main pancreatic duct, which was dilated throughout the pancreas, were observed, and the mass was diagnosed as an adenocarcinoma on EUS-FNA. Based on these findings, main-duct IPMN was suspected and total pancreatectomy was performed. On macroscopic observation of the resected specimen, outgrowth of a solid tumor was observed in the main pancreatic duct, whereas only low-level mucus retention was noted in the pancreatic duct. Histopathological examination revealed a papillary/tubular tumor growth, suggesting interstitial infiltration throughout the pancreas. On immunostaining, the tumor was partially positive for MUC5AC, based on which the patient was diagnosed with an intraductal pancreatic mallignant tumor, with difficulty in differentiating between IPMC and ITPC. Clinicopathologically, many aspects regarding ITPN remain unclear. Further accumulation of such cases and investigation of the tumor pathology are necessary.


Subject(s)
Adenocarcinoma, Mucinous , Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms/pathology , Adenocarcinoma, Mucinous/diagnosis , Adenocarcinoma, Mucinous/surgery , Carcinoma, Pancreatic Ductal/surgery , Humans , Male , Middle Aged , Pancreatectomy , Pancreatic Ducts/pathology , Pancreatic Ducts/surgery , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/surgery
9.
BMC Surg ; 17(1): 52, 2017 May 08.
Article in English | MEDLINE | ID: mdl-28482819

ABSTRACT

BACKGROUND: This retrospective study aimed to investigate the incidence of each type of accessory hepatic duct by drip infusion cholangiography with CT (DIC-CT). METHODS: Five hundred sixty nine patients who underwent preoperative DIC-CT and laparoscopic cholecystectomy were reviewed. Accessory hepatic ducts were classified as follows: type I (accessory hepatic ducts that merged with the common hepatic duct between the confluence of the right and left hepatic ducts and the cystic duct confluence), type II (those that merged with the common hepatic duct at the same site as the cystic duct), type III (those that merged with the common bile duct distal to the cystic duct confluence), type IV (the cystic duct merged with the accessory hepatic duct), and type V (accessory hepatic ducts that merged with the common hepatic or bile duct on the left side). RESULTS: Accessory hepatic ducts were observed in 50 patients. Type I, II, III, IV, and V accessory hepatic ducts were detected in 32, 3, 1, 11, and 3 patients, respectively. Based on their drainage areas, the accessory hepatic ducts were also classified as follows: a posterior branch in 22 patients, an anterior branch in 9 patients, a combination of posterior and anterior branches in 16 patients, a left-sided branch in 2 patients, and a caudate branch in 1 patient. None of the patients with accessory hepatic ducts suffered bile duct injuries. CONCLUSION: There are a number of variants of the accessory hepatic duct. DIC-CT is useful to detect the accessory hepatic duct.


Subject(s)
Cholangiography/methods , Cholecystectomy, Laparoscopic/methods , Hepatic Duct, Common/abnormalities , Tomography, X-Ray Computed/methods , Common Bile Duct , Humans , Infusions, Intravenous , Retrospective Studies
10.
Gan To Kagaku Ryoho ; 44(12): 1928-1929, 2017 Nov.
Article in Japanese | MEDLINE | ID: mdl-29394823

ABSTRACT

A hypervascularized tumor was detected in a 65-year-old man who had underwent a nephrectomy for a right renal cell carcinoma at the age of 55 years. We diagnosed the tumor as a non-functioning pancreatic neuroendocrine tumor or a metastatic tumor from the renal cell carcinoma. We performed distal pancreatectomy with splenectomy and lymph node dissection. The tumor was histopathologically diagnosed as metastatic renal cell carcinoma.


Subject(s)
Carcinoma, Renal Cell/secondary , Kidney Neoplasms/pathology , Pancreatic Neoplasms/secondary , Aged , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/surgery , Diagnosis, Differential , Humans , Kidney Neoplasms/surgery , Male , Nephrectomy , Pancreatectomy , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/surgery , Tomography, X-Ray Computed
11.
Int J Mol Sci ; 17(9)2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27598137

ABSTRACT

MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene expression and play important roles in various physiological and developmental processes such as oncogenic or tumor suppressive regulators. Specific miRNA expression signatures have been identified in a number of human cancers. Cell-free miRNAs have recently been stably detected in plasma and serum (circulating miRNAs), and their presence in blood has attracted the attention of researchers due to their potential as non-invasive biomarkers. Circulating miRNAs have emerged as tumor-associated biomarkers that reflect not only the existence of early-stage tumors, but also the dynamics and status of advanced stage tumors, tumor recurrence, and drug sensitivities. This methodology for liquid biopsy may provide non-invasive and reproductive biomarkers and individualized therapeutic strategies for cancer patients. We herein review the current phase of biological and clinical research on the circulating miRNAs of solid cancers, particularly digestive tract cancers, and discuss future perspectives. The present review may be beneficial for future research on miRNAs used to detect various cancers.


Subject(s)
Biomarkers, Tumor/blood , Gastrointestinal Neoplasms/blood , MicroRNAs/blood , Drug Resistance, Neoplasm , Gastrointestinal Neoplasms/drug therapy , Humans
12.
Oncotarget ; 7(38): 62034-62048, 2016 Sep 20.
Article in English | MEDLINE | ID: mdl-27566562

ABSTRACT

BACKGROUND: This study aims to explore novel microRNAs in plasma for predicting chemoresistance in preoperative chemotherapy of patients with esophageal squamous cell carcinoma (ESCC) using a microRNA array-based approach. RESULTS: (1) Four candidate microRNAs (miR-223, 103a, 23b and 23a), which were highly expressed in the pretreatment plasma of patients with a low histopathologic response, were selected. (2) In a large-scale validation analysis by quantitative RT-PCR, plasma levels of miR-223, miR-23b and miR-23a were significantly higher in patients with a low histopathologic response than in those with a high histopathologic response (p = 0.0345, p = 0.0125 and p = 0.0114). (3) Of all candidate microRNAs, miR-23a expression of pretreatment ESCC tumor tissues was significantly higher in ESCC patients with a low histopathologic response than in those with a high histopathologic response (p = 0.0278). (4) After overexpressing each candidate in ESCC cells, miR-23a induced significant chemoresistance to both 5-fluorouracil and cisplatin, and miR-223 to cisplatin in vitro. (5) A high level of plasma miR-23a, which tended to correlate with lymphatic invasion (p = 0.0808) and deep depth of invasion (p = 0.0658), was an independent risk factor for chemoresistance in ESCC (p = 0.0222; odds ratio: 12.4; range 1.46-105). MATERIALS AND METHODS: We used the Toray® 3D-Gene microRNA array-based approach to compare plasma microRNA levels between patients with a high or a low histopathologic response to chemotherapy. All patients underwent a preoperative chemotherapy regimen with cisplatin plus 5-fluorouracil. CONCLUSIONS: Plasma miR-23a might be a useful biomarker for predicting chemoresistance in ESCC patients.


Subject(s)
Carcinoma, Squamous Cell/genetics , Drug Resistance, Neoplasm , Esophageal Neoplasms/genetics , Gene Expression Regulation, Neoplastic , MicroRNAs/blood , Aged , Biomarkers, Tumor/blood , Cisplatin/administration & dosage , Drug Resistance, Neoplasm/genetics , Female , Fluorouracil/administration & dosage , Fluorouracil/therapeutic use , Gene Expression Profiling , Humans , Lymphatic Metastasis , Male , MicroRNAs/genetics , Middle Aged , Neoplasm Invasiveness , Odds Ratio , Prognosis , Risk Factors
13.
Anticancer Res ; 35(4): 2191-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25862877

ABSTRACT

BACKGROUND/AIM: Although laparoscopy-assisted gastrectomy (LAG) is widely used for the treatment of gastric cancer, its safety and feasibility for elderly patients remains controversial. We herein examined the impact of age on the early surgical outcomes of LAG with suprapancreatic nodal dissection for elderly patients with clinical stage I gastric cancer. PATIENTS AND METHODS: This retrospective study included 292 patients undergoing LAG with suprapancreatic nodal dissection for clinical stage I gastric cancer. We divided patients into an elderly group (age ≥ 75 years; n=55) and non-elderly group (age <75 years; n=237). Preoperative conditions, operative findings and postoperative outcomes, including complications, were compared between these two groups. RESULTS: The elderly group had a higher incidence of co-morbidities (61.8%) and lower forced expiratory volume in 1 second/forced vital capacity (74.8%). Preoperative levels of hemoglobin (Hb) and serum albumin (Alb), as well as the total lymphocyte count (TLC) were lower in the elderly group (p<0.001, <0.001 and =0.018, respectively). No significant differences were observed in intraoperative findings between the two groups. The incidence of overall and surgical complications in the elderly group (21.8% and 14.5%, respectively) did not significantly differ from those in the non-elderly group. The frequency of non-surgical complications in the elderly group (9.1%) was significantly higher (p =0.018), whereas no critical complications or mortality were observed. No significant differences were noted in the severity of complications or hospital courses between the groups. CONCLUSION: LAG with suprapancreatic nodal dissection appears to be safe and feasible for elderly patients with clinical stage I gastric cancer.


Subject(s)
Gastrectomy/methods , Laparoscopy/methods , Lymph Node Excision , Stomach Neoplasms/surgery , Aged , Aged, 80 and over , Female , Humans , Lymph Nodes/surgery , Male , Postoperative Complications/pathology , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Treatment Outcome
14.
Gastric Cancer ; 18(2): 271-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24626859

ABSTRACT

BACKGROUND: Recently, circulating microRNAs have been reported to be stably detectable in plasma/serum and to function as potent non-invasive biomarkers in various cancers. We hypothesized that miR-18a could contribute to a novel plasma biomarker in patients with gastric cancer (GC). METHODS: We focused on miR-18a, which is a component of miR-17-92 cluster and has been reported as highly expressed in GC tissues. The study involved three steps: (1) confirmation of the higher miR-18a expression in primary GC tissues and GC cell lines than in normal gastric tissues and a fibroblast cell line; (2) evaluation of the plasma miR-18a assay using quantitative RT-PCR by comparing 104 GC patients and 65 healthy volunteers; (3) evaluation of monitoring tumor dynamics by the plasma miR-18a assay. RESULTS: (1) The miR-18a expressions were significantly higher in GC tissues than in normal gastric tissues (P = 0.0286) and higher in all examined GC cell lines than in the fibroblast cell line. (2) The plasma miR-18a concentrations were significantly higher in GC patients than in healthy controls (P < 0.0001). The value of the area under the receiver-operating characteristic curve was 0.8059. (3) The plasma miR-18a levels were significantly reduced in postoperative samples compared to in preoperative samples (P = 0.0002). In an miR-18a overexpressing cell line, the miR-18a concentration of cultured medium increased in both cell number and time-course dependent manners, suggesting microRNA might be released from cancer cells into the surrounding environment. CONCLUSIONS: Circulating miR-18a could be a useful biomarker for screening GC and monitoring tumor dynamics.


Subject(s)
Adenocarcinoma/genetics , Biomarkers, Tumor/genetics , MicroRNAs/genetics , Neoplasm Recurrence, Local/genetics , Stomach Neoplasms/genetics , Adenocarcinoma/blood , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Case-Control Studies , Cell Differentiation , Cell Proliferation , Cells, Cultured , Early Detection of Cancer , Female , Fibroblasts , Follow-Up Studies , Humans , Male , MicroRNAs/blood , Middle Aged , Neoplasm Invasiveness , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Prognosis , ROC Curve , Real-Time Polymerase Chain Reaction , Stomach Neoplasms/blood , Stomach Neoplasms/pathology
15.
In Vivo ; 28(3): 293-7, 2014.
Article in English | MEDLINE | ID: mdl-24815829

ABSTRACT

MicroRNAs have been reported to be stably detectable in plasma/serum and to exhibit resistance to endogenous ribonuclease activity because of binding to proteins such as Argonaute-2 and high-density lipoprotein, or being packed by secretory particles such as exosomes. These secretory particles include specific microRNAs and can function as intercellular transmitters. These findings could open-up a new and promising field in the use of circulating microRNAs for cancer treatment. In particular, miR-18a, which is located in the potentially oncogenic miR-17-92 cluster, is a highly expressed microRNAs in several types of cancers. The concentration of miR-18a in plasma/serum of patients with cancer such as esophageal (AUC=0.944), pancreatic (AUC=0.936), hepatocellular (AUC=0.881), colorectal and other types of cancers is much higher than that of healthy volunteers. Such reports provide evidence that circulating miR-18 might be a next-generation biomarker and contribute to cancer screening in non-invasive liquid biopsy, to a clinically-satisfactory degree of sensitivity and specificity.


Subject(s)
Biomarkers, Tumor , MicroRNAs/blood , MicroRNAs/genetics , Neoplasms/blood , Neoplasms/genetics , Cell Transformation, Neoplastic/genetics , Early Detection of Cancer , Gene Expression Regulation, Neoplastic , Humans , Multigene Family , Neoplasms/diagnosis , Prognosis
16.
Dig Dis Sci ; 59(6): 1152-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24458211

ABSTRACT

BACKGROUND: This study was designed to evaluate the clinical benefit of predicting the cyclin D1 (CCND1) status using cell-free plasma DNA in superficial esophageal squamous cell carcinoma (ESCC) patients. METHODS: The ratio of the CCND1 (11q13) dosage to the DRD2 (11q22-23) dosage (C/D ratio) as the CCND1 copy number was evaluated. This study was divided into three steps: (1) demonstration of the feasibility, (2) evaluation of whether the plasma C/D ratio assay could monitor tumor dynamics, and (3) a validation study in 63 consecutive superficial ESCC (pTis-T1) patients and 40 healthy volunteers. RESULTS: (1) The plasma C/D ratio was significantly higher (p = 0.0369) in superficial ESCC patients than in the controls in a preliminary test. (2) The high plasma C/D ratio appeared to reflect the tumor levels of the CCND1 status and was reduced in postoperative plasma samples (p = 0.1154) and samples following endoscopic resection (p = 0.0845). (3) Validation analysis revealed that the plasma C/D ratio was significantly higher in superficial ESCC patients than in controls (p < 0.0001). The frequency of recurrence was significantly higher (p = 0.0198), and recurrence-free survival was significantly shorter (p = 0.0075) in patients with a high plasma C/D ratio. Moreover, a high C/D ratio was shown to be an independent risk factor for recurrence on multivariate analysis [p = 0.0334; odds ratio 10.58 (range 1.203-93.23)]. CONCLUSION: The prediction of CCND1 amplification by plasma DNA may be a new complementary clinical biomarker for recurrence in patients with superficial ESCC.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Cyclin D1/blood , Cyclin D1/metabolism , DNA/blood , Esophageal Neoplasms/metabolism , Aged , Biomarkers, Tumor/blood , Carcinoma, Squamous Cell/blood , Esophageal Neoplasms/blood , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged
17.
J Gastroenterol ; 49(5): 853-63, 2014 May.
Article in English | MEDLINE | ID: mdl-23771433

ABSTRACT

BACKGROUND: xCT is a component of the cysteine/glutamate transporter, which plays a key role in glutathione synthesis. The objectives of the present study were to investigate the role of xCT in the regulation of genes involved in cell cycle progression and the clinicopathological significance of its expression in esophageal squamous cell carcinoma (ESCC). METHODS: xCT expression in human ESCC cell lines was analyzed by Western blotting and immunofluorescent staining. Knockdown experiments were conducted with xCT siRNA, and the effect on cell cycle was analyzed. The cells' gene expression profiles were analyzed by microarray analysis. An immunohistochemical analysis of 70 primary tumor samples obtained from ESCC patients that had undergone esophagectomy was performed. RESULTS: xCT was highly expressed in TE13 and KYSE170 cells. In these cells, the knockdown of xCT using siRNA inhibited G1-S phase progression. Microarray analysis identified 1652 genes whose expression levels in TE13 cells were altered by the knockdown of xCT. Pathway analysis showed that the top-ranked canonical pathway was the G1/S checkpoint regulation pathway, which involves TP53INP1, CDKN1A, CyclinD1/cdk4, and E2F5. Immunohistochemical staining showed that xCT is mainly found in the nuclei of carcinoma cells, and that its expression is an independent prognostic factor. CONCLUSIONS: These observations suggest that the expression of xCT in ESCC cells might affect the G1/S checkpoint and impact on the prognosis of ESCC patients. As a result, we have a deeper understanding of the role played by xCT as a mediator and/or biomarker in ESCC.


Subject(s)
Amino Acid Transport System y+/genetics , Carcinoma, Squamous Cell/genetics , Esophageal Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Blotting, Western , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Esophageal Neoplasms/pathology , Esophageal Squamous Cell Carcinoma , G1 Phase Cell Cycle Checkpoints/genetics , Gene Expression Profiling , Gene Knockdown Techniques , Humans , Microarray Analysis , Prognosis , RNA, Small Interfering/administration & dosage , S Phase Cell Cycle Checkpoints/genetics
18.
World J Surg ; 37(12): 2891-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24081528

ABSTRACT

BACKGROUND: This study was designed to determine the surgical outcomes of gastric cancer in elderly patients. This information can help establish appropriate treatment for these patients. METHODS: A total of 1,193 patients with gastric cancer who underwent gastrectomy between 1995 and 2010 were enrolled in this retrospective study. The clinicopathologic features of 104 elderly patients (aged ≥80 years) were compared with those of 1,089 nonelderly patients. RESULTS: (1) Tumors located in the lower-third of the stomach, differentiated cancer, and surgery with limited lymph node dissection were more common in elderly patients. However, there was no difference in the proportion of laparoscopic gastrectomy between elderly and nonelderly patients. (2) Although surgical complication rates were similar in the two groups, the operative mortality rate was higher in elderly patients (1.9 %) than in nonelderly patients (0.7 %). (3) Elderly patients had a significantly poorer overall survival rate, whereas the disease-specific survival rates of the two groups were similar. Limited lymph node dissection did not influence the disease-specific survival rate of elderly patients. (4) The median life expectancy of elderly gastric cancer survivors was 9.8 years in patients aged 80-84 years and 6.0 years in those ≥85 years. The patients with limited lymph node dissection had slightly better prognosis. CONCLUSIONS: The treatment results in elderly patients were comparable to those in nonelderly patients. These findings suggest that R0 resection with at least limited lymph node dissection according to Japanese guidelines should be considered, even for elderly patients.


Subject(s)
Adenocarcinoma/surgery , Gastrectomy , Stomach Neoplasms/surgery , Abdomen , Adenocarcinoma/mortality , Adult , Age Factors , Aged , Aged, 80 and over , Female , Gastrectomy/methods , Gastrectomy/mortality , Humans , Kaplan-Meier Estimate , Laparoscopy , Lymph Node Excision , Male , Middle Aged , Neoplasm Staging , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies , Stomach Neoplasms/mortality , Survival Rate , Treatment Outcome
19.
PLoS One ; 8(3): e59057, 2013.
Article in English | MEDLINE | ID: mdl-23527086

ABSTRACT

XB130, a novel adaptor protein, promotes cell growth by controlling expression of many related genes. MicroRNAs (miRNAs), which are frequently mis-expressed in cancer cells, regulate expression of targeted genes. In this present study, we aimed to explore the oncogenic mechanism of XB130 through miRNAs regulation. We analyzed miRNA expression in XB130 short hairpin RNA (shRNA) stably transfected WRO thyroid cancer cells by a miRNA array assay, and 16 miRNAs were up-regulated and 22 miRNAs were down-regulated significantly in these cells, in comparison with non-transfected or negative control shRNA transfected cells. We chose three of the up-regulated miRNAs (miR-33a, miR-149 and miR-193a-3p) and validated them by real-time qRT-PCR. Ectopic overexpression of XB130 suppressed these 3 miRNAs in MRO cells, a cell line with very low expression of XB130. Furthermore, we transfected miR mimics of these 3 miRNAs into WRO cells. They negatively regulated expression of oncogenes (miR-33a: MYC, miR-149: FOSL1, miR-193a-3p: SLC7A5), by targeting their 3' untranslated region, and reduced cell growth. Our results suggest that XB130 could promote growth of cancer cells by regulating expression of tumor suppressive miRNAs and their targeted genes.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Base Pairing , Base Sequence , Cell Line, Tumor , Cell Proliferation , Gene Expression , Gene Expression Profiling , Humans , MicroRNAs/chemistry , Molecular Sequence Data , RNA Interference , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Transfection
20.
Anticancer Res ; 33(1): 271-6, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23267156

ABSTRACT

BACKGROUND: MicroRNAs (miRNAs) such as miR-17-5p, miR-21, miR-106a and miR-106b are reported to be highly expressed in gastric carcinoma (GC) tissues. Recently, we reported that these miRNAs were consistently detectable in plasma and reflected tumor dynamics of GC. We hypothesized that these plasma miRNA concentrations could be used as prognostic markers in patients with GC. MATERIALS AND METHODS: Between 2008 and 2009, preoperative plasma samples were collected from 69 consecutive patients with GC at our hospital. We retrospectively examined the association between plasma miRNA concentrations and prognosis. RESULTS: The postoperative cause-specific survival rate of patients with high plasma miR-21 concentration was significantly poorer than those with a low concentration (p=0.0451), as was that of those with high plasma concentration of miR-106a (p=0.1132). There were no prognostic differences according to the plasma concentration of miR-17-5p and miR-106b. Those with high miR-21 concentration had also a slightly higher incidence of vascular invasion (p=0.0311). Multivariate analysis revealed that the presence of a high miR-21 concentration in plasma was an independent prognostic factor (p=0.0133, hazard ratio: 13.4 (95% CI: 1.72-104.4)). CONCLUSION: The level of circulating miR-21 could be a reliable prognostic marker in the plasma of patients with GC. These findings contribute to the stratification of patients in order to identify those who need meticulous follow-up for early detection of recurrence and additional or alternative treatments of GC.


Subject(s)
Carcinoma/blood , MicroRNAs/blood , Prognosis , Stomach Neoplasms/blood , Aged , Biomarkers, Tumor/blood , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged , Neoplasm Staging , Retrospective Studies , Stomach Neoplasms/pathology , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...